Biotechnology News and Research

RSS

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions.

From Sphere Fluidics 19 Dec 2023

Transgenic carrots producing nisin protein show promise as natural food preservatives

Study explores the production of nisin protein in transgenic carrots, demonstrating its potential as a natural preservative effective against bacterial pathogens in food and juices.

18 Dec 2023

€7.4M EU grant boosts development of vaccines against Marburg viruses

International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.

18 Dec 2023

Oxidized amino acids signal damaged photosynthesis proteins for repair

Photosynthesis refers to the fundamental biological process of the conversion of light energy into chemical energy by chlorophyll (a green pigment) containing plants.

18 Dec 2023

Deep learning designs high-affinity protein binders for bioactive helical peptides

A new study Dec. 18 in Nature reports an AI-driven advance in biotechnology with implications for drug development, disease detection, and environmental monitoring.

18 Dec 2023

Unlocking the secrets of our "dark genome": Scientists crack the code of LINE-1

A multidisciplinary study published in Nature has elucidated the structure of the machinery responsible for writing much of our "dark genome" -; the 98 percent of our DNA that has largely unknown biological function.

14 Dec 2023

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move that could bolster the continent’s efforts to address historical dependence on imported vaccines and establish its own robust biotechnology sector.

12 Dec 2023

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

From Himedia Laboratories Private Limited 12 Dec 2023

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.

From SolasCure 12 Dec 2023

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

8 Dec 2023

Expanding the toolbox for drug design: New enzymes for tailoring molecules

Simon Schröder has worked out how enzymes can be used to more easily form the desired bond between two nitrogen atoms.

8 Dec 2023

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

A team of researchers based at the University of Toronto's (U of T) Leslie Dan Faculty of Pharmacy has discovered a novel ionizable lipid nanoparticle that enables muscle-focused mRNA delivery while minimizing off-target delivery to other tissues.

8 Dec 2023

UTA receives $1.1 million grant to train researchers in mathematical and computational methods for health

The National Science Foundation (NSF) has awarded The University of Texas at Arlington a $1.1 million grant to train and mentor three multi-level cohorts of interdisciplinary researchers in mathematical and computational techniques to address questions in cancer biology, computational neurology and vector-borne diseases.

7 Dec 2023

New drug combo fights breast cancer with brain metastases

A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival among patients with unresectable locally advanced or metastatic HER2-positive breast cancer, compared with T-DM1 alone, according to results from the HER2CLIMB-02 trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

6 Dec 2023

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.

From Camena Bioscience 6 Dec 2023

Organoid model unveils secrets of the brain's dopaminergic system

A new organoid model of the dopaminergic system sheds lights on its intricate functionality and potential implications for Parkinson's disease.

5 Dec 2023

The past, present and future of automation and digitalization in the life sciences laboratory

In this interview, News-Medical talks to Dr. Klaus Lun and Chris Mason about the past, present and future of automation and digitalization in the life sciences laboratory and especially the impact this could have on next-generation sequencing and genomics.

From Tecan 5 Dec 2023

New orthopedic implant coating can ward off infection

Superior knee and hip replacements are a step closer after Flinders University and Chinese researchers further test and develop a new orthopedic implant coating which has the strong ability to ward off infection – as well as stimulate bone growth.

5 Dec 2023

New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system

The recent publication in Science by Mogila, Tamulaitiene et al. represents a continuation of the successful scientific research conducted by Gintautas Tamulaitis' group.

4 Dec 2023

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need.

29 Nov 2023

Biotechnology News and Research

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

Transgenic carrots producing nisin protein show promise as natural food preservatives

€7.4M EU grant boosts development of vaccines against Marburg viruses

Oxidized amino acids signal damaged photosynthesis proteins for repair

Deep learning designs high-affinity protein binders for bioactive helical peptides

Unlocking the secrets of our "dark genome": Scientists crack the code of LINE-1

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

Expanding the toolbox for drug design: New enzymes for tailoring molecules

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

UTA receives $1.1 million grant to train researchers in mathematical and computational methods for health

New drug combo fights breast cancer with brain metastases

Camena Bioscience appoints Dr. Nicola Thompson as Chair of the Board

Organoid model unveils secrets of the brain's dopaminergic system

The past, present and future of automation and digitalization in the life sciences laboratory

New orthopedic implant coating can ward off infection

New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Biotechnology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News